Adial Pharmaceuticals, Inc. Gains 59.8%
Fri, Mar 01, 2024 at 07:12 PM
Adial Pharmaceuticals, Inc. (ADIL:NASDAQ) rocketted at $3.26, representing a gain of 59.8%. On Fri, Mar 01, 2024, ADIL:NASDAQ touched a New 2-Week High of $3.26. The stock appeared on our News Catalysts scanner on Wed, Feb 28, 2024 at 01:48 PM in the 'PATENT' category. From Fri, Feb 16, 2024, the stock recorded 44.44% Up Days and 50.00% Green Days
The stock spiked on Fri, Mar 01, 2024 at $4.17 with a volume of 77M+.
About Adial Pharmaceuticals, Inc. (ADIL:NASDAQ)
Adial Pharmaceuticals Inc is a United States-based pharmaceutical company. The company develops prescription medications for addiction and related disorders.
Top 10 Gainers:
- Unico American Corporation (UNAM:NASDAQ), 203.03%
- Sizzle Acquisition Corp. (SZZL:NASDAQ), 125.23%
- Mmtec, Inc. (MTC:NASDAQ), 96.92%
- Cardiff Oncology Inc. (CRDF:NASDAQ), 64.87%
- Adial Pharmaceuticals, Inc. (ADIL:NASDAQ), 59.8%
- The RealReal, Inc. (REAL:NASDAQ), 55.93%
- Roma Green Finance Limited (ROMA:NASDAQ), 51.11%
- Jaguar Health, Inc. (JAGX:NASDAQ), 50%
- JanOne Inc. (JAN:NASDAQ), 46.33%
- Xponential Fitness Inc. Class A (XPOF:NYSE), 39.38%